Rocket Fuel
Prescribing Information Important Safety Information Amgen MedInfo Live Assistance For Patients

Support programs are available for patients taking Neulasta®

Neulasta® patients who need financial assistance may be eligible for assistance from several sources. These include:

  • Independent co-pay foundations
  • The Safety Net Foundation, which provides Neulasta® at no cost for eligible patients
  • The Neulasta® Co-Pay Coupon Program

87% of Neulasta® patients had $0 out-of-pocket costs, based on a national claims database*1

Your patients may be eligible for the Neulasta® Co-Pay Coupon Program

The Neulasta FIRST STEP® Program is a medical benefit co-pay coupon program to help commercially insured eligible patients with their deductible, co-insurance, and/or co-pay requirements for Neulasta® (pegfilgrastim).

  • 100% of an eligible patient's combined co-payment, co-insurance, or deductible will be covered for the patient's first injection of Neulasta® covered by the Neulasta FIRST STEP® Program
  • For all subsequent injections of Neulasta®, Amgen will pay the eligible patient's combined out-of-pocket co-payment, co-insurance, or deductible amount in excess of $25 per dose for a total program benefit up to $5,000 per patient per 6-month period
  • The 6-month program periods run from January 1 through June 30 and July 1 through December 31

Eligible patients can be enrolled in the program and receive program benefits across program benefit periods.

  • The $5,000 cap simply restarts on the first day of the new 6-month program period cycle until the patient’s treatment regimen ends or the program is discontinued, whichever is sooner
  • Once registered, the Neulasta FIRST STEP® Card is valid for the enrolled patient’s entire course of Neulasta® treatment
  • Eligible patients may re-enroll at any time a new course of treatment with Neulasta® is initiated

The Neulasta FIRST STEP® Program may help eligible patients with out-of-pocket costs associated with Neulasta® purchased and administered at a participating clinic or institution.

  • The program does not cover costs associated with a patient visit including physician, staff, or administrative charges associated with administering Neulasta®, or the out-of-pocket costs for Neulasta® purchased at a specialty or retail pharmacy and then administered at a clinic or institution
  • A clinic or institution must first be enrolled before a patient can participate in this program
  • Amgen reserves the right to deny payment under the Neulasta FIRST STEP® Program to anyone deemed ineligible in accordance with the stated criteria

Enrolling your practice

To enroll your practice in the Amgen FIRST STEP® Program, please call 1-888-65-STEP1 (1-888-657-8371). Offices must complete this process once prior to processing the Amgen FIRST STEP® Program Cards.

*National claims database included 41,237 patients, across all insurance types, between January 2011 and October 2012.

Eligibility Criteria: Most patients who have commercial insurance are eligible to enroll in the Neulasta® Co-Pay Coupon Program, once their physician has determined that Neulasta® is right for them. Not open to uninsured patients or patients covered by federal, state, or government-funded insurance programs (Medicare, Medicaid, etc.), or where prohibited by law. Restrictions apply. Offer subject to change or discontinuation without notice. This is not health insurance.

  Next:

Learn about assistance for uninsured patients

Reference:

  1. Data on file, Amgen.
Indication and Important Safety Information
SEE MORE